US EditionCardiol Therapeutics (NASDAQ:CRDL) Coverage Initiated at HC Wainwright
Summary by themarketsdaily.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Cardiol Therapeutics (NASDAQ:CRDL) Coverage Initiated at HC Wainwright
HC Wainwright initiated coverage on shares of Cardiol Therapeutics (NASDAQ:CRDL – Free Report) in a report issued on Monday, MarketBeat Ratings reports. The brokerage issued a buy rating and a $9.00 price target on the stock. HC Wainwright also issued estimates for Cardiol Therapeutics’ Q2 2025 earnings at ($0.12) EPS, Q3 2025 earnings at ($0.12) […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
